Dual immune checkpoint blockade for non-small cell lung cancer patients with PD-L1 high expression: calling an end?
2020 ◽
Vol 21
(5)
◽
pp. e497-e510
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 13
(10)
◽
pp. S874
◽
Keyword(s):